Biomea Fusion, Inc. (BMEA) stock

BMEANasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30

$0.56−0.05 (-7.89%)

Close on Nov 12, 2026Market cap $40.79MP/E –Yield –

Biomea Fusion price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Biomea Fusion has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?